Scholars Central

Conference abstractPublished 20 Jul 2022

PLGA nano carrier for targeted delivery of drugs in neuroinflammation

Authors: Abhijeet Singh, Vandana Kumari, Bjorn John Stephen, Madan Mohan Sharma

Manipal University Jaipur, India

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Nanoscience and nanotechnology have shown unparalled growth in research and applications in recent years. There is growing hope that nanotechnology, when applied to medicine, will lead to significant advancements in disease diagnosis and treatment. Drug delivery, both in vitro and in vivo diagnostics, nutraceuticals, elicits development of more biocompatible materials for use in medicinal field. Neuroinflammation, the response of the central nervous system (CNS) to disturbed homeostasis, typifies all neurological diseases, including developmental, traumatic, ischemic, neoplastic, infectious and neurodegenerative disorders. From several vantage point, the brain is the most arduous organ for delivering drugs. First, as the population ages, the prevalence of degenerative brain illnesses will rise. Second, the bloodbrain barrier (BBB) is well-known as the body's finest drug gatekeeper against the exogenic substances. Dexamethasone is known to inhibit inflammatory response, the severe side effects associated with high dose of glucocorticoids required to reach therapeutic value, is one of the main reasons for not using dexamethasone as a neuroprotective agent. Nanotechnology offers a suitable alternative route in drug delivery. In particular, the rationale of using nanoparticle (NPs) for brain drug delivery may promote their targeting of the BBB and the enhancement of its crossing. Poly lacticco- glycolic acid (PLGA) is the most studied and best defined polymer, approved by the Food and Drug Administration of USA (FDA) for drug delivery and pharmacological studies. In this study we attempted to determine the most efficient method for the synthesis of doped PLGA nanoparticles for drug delivery applications and varying the type of surfactants used and its role in drug delivery.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Infectious Diseases & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Infectious Diseases & Therapy
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Abhijeet Singh”
  • BylineArticles whose byline prints “Vandana Kumari”
  • BylineArticles whose byline prints “Bjorn John Stephen”
  • BylineArticles whose byline prints “Madan Mohan Sharma”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels